Brief: Shenzhen Neptunus Interlong Bio-technique Co says qtrly revenue hk$188 mln vs rmb192.2 mln
14/08/2017 15:55
Aug 14 (Reuters) - Shenzhen Neptunus Interlong Bio-technique
Co Ltd 8329.HK
* Qtrly profit and total comprehensive income for period
attributable to owners of co rmb10.5 million versus hk$11.4
million
* Qtrly revenue hk$188 million versus rrmb192.2 million
Source text for Eikon: ID:nHKSfmxYF
Further company coverage: 8329.HK
(bangalore.newsroom@thomsonreuters.com)
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million